Spectral AI Stock (NASDAQ:MDAI)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$1.64

52W Range

$1.18 - $2.97

50D Avg

$1.91

200D Avg

$1.77

Market Cap

$52.19M

Avg Vol (3M)

$579.42K

Beta

1.17

Div Yield

-

MDAI Company Profile


Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient’s wounds. Its system also includes MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images; and AI-Burn software. Spectral AI, Inc. is headquartered in Dallas, Texas.

Show More

Industry

Medical - Specialties

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

65

IPO Date

Apr 06, 2021

Website

MDAI Performance


MDAI Financial Summary


Dec 25Dec 24Dec 23
Revenue$19.65M$29.58M$18.06M
Operating Income$-8.60M$-6.58M$-12.98M
Net Income$-7.57M$-15.31M$-20.85M
EBITDA$-7.97M$-11.49M$-20.12M
Basic EPS$-0.29$-0.85$-1.48
Diluted EPS$-0.29$-0.85$-1.48

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q4 25Mar 24, 26 | 5:00 PM
Q3 25Nov 11, 25 | 5:00 PM
Q2 25Aug 12, 25 | 5:00 PM

Peer Comparison


TickerCompany
IPSCCentury Therapeutics, Inc.
EQEquillium, Inc.
ICCMIceCure Medical Ltd
TELATELA Bio, Inc.
SRTSSensus Healthcare, Inc.
CTSOCytosorbents Corporation
TELOTelomir Pharmaceuticals, Inc. Common Stock
KPTIKaryopharm Therapeutics Inc.
ECORelectroCore, Inc.